Gilead Sciences to Present at Two Upcoming Investor Conferences
February 24 2012 - 4:30PM
Business Wire
Gilead Sciences, Inc. (Nasdaq:GILD) announced today that the
company will be webcasting its corporate presentation at two
upcoming investor conferences: the Citi Global Healthcare
Conference and the RBC Capital Markets’ Healthcare Conference, both
taking place in New York.
John F. Milligan, PhD, Gilead’s President and Chief Operating
Officer, and Kevin Young CBE, Gilead’s Executive Vice President,
Commercial Operations, will provide an overview of the company at
the Citi conference on Monday, February 27 at 8:30 a.m. Eastern
Standard Time (EST) and the RBC conference on Tuesday, February 28
at 10:30 a.m. EST.
To access the live webcasts or replays via the internet log on
to www.gilead.com. Please connect to the company’s website at least
15 minutes prior to the start of the presentation to ensure
adequate time for any software download that may be necessary to
listen to the webcast. The replay will be available for 14 days
following the presentation.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company’s mission is to advance the care of
patients suffering from life-threatening diseases worldwide.
Headquartered in Foster City, California, Gilead has operations in
North America, Europe and Asia Pacific.
For more information on Gilead Sciences, please
visit www.gilead.com or call the Gilead Public Affairs Department
at 1-800-GILEAD-5 (1-800-445-3235).
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From May 2024 to Jun 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jun 2023 to Jun 2024